MYM Nutraceuticals Inc. , (CSE: MYM) (OTC: MYMMF), is extremely pleased to announce the completion of the architectural layout and security plans for phase one ACMPR greenhouses for the Weedon, QC project.
Articles
CannaVision Secures Medical Marijuana Clinic Facility in Coral Gables, Florida
StereoVision Entertainment, Inc. (OTC PINK: SVSN), a publicly traded Nevada company, announced today that their majority owned medical cannabis and organic/industrial hemp subsidiary, CannaVision, has secured a medical marijuana clinic facility in Coral Gables, Florida.
ChineseInvestors.com, Inc. (CIIX) Announces Establishment of Hemp Education Center
Through this club-style education center, the company aims to provide valuable information to those who want to learn more about the potential health benefits of non-industrial hemp and hemp-derived cannabidiol (CBD).
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol
A new scientific review of the safety and side effects of cannabidiol confirms and expands on the myriad known health benefits of cannabidiol and the compound’s lack of side effects.
Canopy Accelerator Invests $1,000,000 in Cannabis Tech Startups in 2017
Canopy , a venture fund and business accelerator for companies developing ancillary products and services for the legal cannabis industry, is pleased to announce the launch of its Fall 2017 class in Boulder, Colorado .
ABcann Global Corp. (TSX.V: Abcn) (OTCQB: Abccf) Moves Closer to Kimmett Expansion with TSXV Approval of Cannabis Wheaton Investment
Cannabis Wheaton Income Corp. (TSX.V: CBW) this morning announced that it has received approval from the TSX Venture Exchange to purchase $15 million of common shares of ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) at an agreed upon valuation of $2.25 per share.
U.S. pot laws are a headache for the TSX
Canada's biggest stock exchange debates U.S. policy
Senate Passes Marijuana Amendment While Trump and Sessions Try to Stop It
With Marijuana state laws threatened, a new amendment could potentially help to give states the rights they deserve. Occurring on July 27th, Senator Patrick Leahy (D-VT) went to the Senate and successfully proposed and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee which will protect lawful medical marijuana programs from being impeded upon by the Dept. of Justice.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Moves Closer to Kimmett Expansion with TSXV Approval of Cannabis Wheaton Investment
Cannabis Wheaton Income Corp. (TSX.V: CBW) this morning announced that it has received approval from the TSX Venture Exchange to purchase $15 million of common shares of ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) at an agreed upon valuation of $2.25 per share.
DOJA Cannabis Company Receives Conditional Approval of CSE Listing
SG Spirit Gold Inc. is pleased to announce that it has received conditional approval from the Canadian Securities Exchange with respect to the proposed three-cornered amalgamation between the Company, Northern Lights Marijuana Company Limited ("DOJA") and a wholly-owned subsidiary of the Company.
Marijuana Company of America Completes $250,000 Investment in MoneyTrac Technology
MARIJUANA COMPANY OF AMERICA, INC. (OTC PINK: MCOA), an innovative cannabis and hemp corporation, is pleased to announce that it has completed an investment of $250,000 into MoneyTrac Technology, Inc. ("MTT"), a subsidiary of Global Payout, Inc. (OTC PINK: GOHE), in exchange for a 15% ownership interest.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Research Published in the European Journal of Pain
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the publication of company-sponsored research in the European Journal of Pain.
Investment Options in the Multi-billion Dollar Medical Marijuana Industry
Mounting research from around the world suggests marijuana's potential to treat multiple medical conditions ranging from chronic pain to cancer, epilepsy, HIV/AIDS, anxiety and more.
ABcann Global (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) Provides Construction and Expansion Update
ABcann Global Corporation (TSX-V:ABCN) (Frankfurt:23Q) (OTCQB:ABCCF) is pleased to provide an update on the Company's construction and expansion timelines for its Vanluven and Kimmett facilities, both located in Napanee, Ontario.
Isodiol International Inc. Announces Unaudited Quarterly Profit of Iso International LLC
Isodiol International Inc. (CSE:ISOL) (OTC:LAGBF) (Frankfurt:LB6A.F) a global cannabis innovator, specializing in the development of pharmaceutical and consumer products, announces the operational numbers of its wholly-owned subsidiary for the period from April 1, 2017 to June 30, 2017.